The Economic Impact of AI in Healthcare

By Sumona Bose

January 23, 2024


The rising cost of medical treatment has become a growing concern, driven by factors such as an increasing population, an aging society, and the prevalence of diseases. However, the integration of Artificial Intelligence (AI) in healthcare offers a promising solution to address these challenges. AI has already proven its superiority in various healthcare applications, including image segmentation, speech recognition, and personal assistants. This study aims to evaluate the economic impact of AI in healthcare, specifically in the areas of diagnosis and treatment, and compare it to traditional methods.

AI’s Economic Advantage

The study is based on two hypotheses: firstly, that AI offers more economic solutions compared to conventional methods, and secondly, that AI treatment offers stronger economics compared to AI diagnosis. To investigate these hypotheses, the researchers utilized the PRISMA methodology to select the best 200 studies on AI in healthcare, with a primary focus on cost reduction in diagnosis and treatment. The researchers defined the architecture of AI-based diagnosis and treatment systems and examined their characteristics. They then categorized the roles that AI plays in the diagnostic and therapeutic paradigms. By integrating AI into these processes and comparing the costs against conventional methods, the researchers were able to assess the economic impact of AI in healthcare.

Figure 1: The generalized architecture of the ML-based system.

Cost Savings and Future Concepts

The results of the study revealed significant cost savings when utilizing AI tools in diagnosis and treatment. The economic benefits of AI can be further enhanced by incorporating pruning techniques to optimize AI algorithms, reducing AI bias, ensuring explainability of AI systems, and obtaining regulatory approvals. Pruning involves removing unnecessary components from AI algorithms, resulting in more efficient and cost-effective systems. By addressing AI bias, healthcare providers can ensure fair and accurate diagnoses and treatments. Explainability of AI systems is crucial for building trust and understanding among healthcare professionals and patients. Regulatory approvals are necessary to ensure the safety and effectiveness of AI technologies in healthcare.


Implications for the Healthcare Industry

The findings of this study have significant implications for the healthcare industry. The integration of AI in diagnosis and treatment can lead to substantial cost savings, making healthcare more affordable and accessible for patients. Additionally, AI can enhance the accuracy and efficiency of medical procedures, improving patient outcomes and reducing the burden on healthcare professionals.


Furthermore, the future concepts of pruning, bias reduction, explainability, and regulatory approvals will play a crucial role in maximizing the economic benefits of AI in healthcare. These concepts will ensure that AI technologies are well placed within HEOR methodologies and evaluation.

Reference url

Recent Posts

Cost and clinical impact of MIS-C

Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndrome in Children (MIS-C)

๐Ÿ” Discovering the Economic Impact of Multisystem Inflammatory Syndrome in Children (MIS-C) ๐Ÿฅ๐Ÿ’ฐ

Understanding the cost and clinical impact of MIS-C during COVID-19 is crucial for healthcare providers and policymakers. Learn about treatment costs, patient outcomes, and key statistics related with MIS-C.

๐ŸŒŸ#Healthcare #MIS-C #COVID19 #Pediatrics #HealthEconomics #MedicalResearch #HealthcareResearch #MedicalEconomics ๐Ÿ“Š

Let’s navigate the intersection of healthcare and economics together! ๐Ÿ’ผ #HealthcareInsights #EconomicAnalysis ๐Ÿง 


Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia

Hepatitis B continues to pose a significant public health challenge, but the World Health Organization continues to work towards achieving their ambition of eliminating HBV as a public health problem by 2030.

One strategy is the Treat All approach, which sounds promising – however, in low-resource settings implementing promising strategies becomes more complex. This study explores striking the balance between promising strategies and getting people the treatment they need.

Learn more about innovative HBV treatment approaches and their impact on global health. Stay informed and join the conversation! ๐Ÿ’ก๐Ÿ”ฌ #HealthcareInnovation #HBVResearch

cost effectiveness multiple sclerosis

Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis

Exploring the Cost-Utility of MS Treatments: A Comprehensive Review ๐Ÿง ๐Ÿ’ผ Dive into the latest findings on the cost-effectiveness of Disease-Modifying Drugs for Multiple Sclerosis. Discover key insights and recommendations for optimizing treatment strategies. #MSresearch #HealthcareEconomics #Neurology #HealthTech ๐Ÿ“Š๐Ÿ”ฌ

When you partner with Syenza, itโ€™s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.



1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA



ยฉ 2024 Syenzaโ„ข. All rights reserved.